20
Participants
Start Date
September 3, 2024
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2025
Placebo (Placebo trial)
The Placebo capsule supplement was taken for 2 weeks (2 capsules per day)
Hesperetin (Hesperetin trial)
The Hesperetin capsule supplement was taken for 2 weeks, with a daily dosage of 500 mg of Hesperetin (equivalent to 2 capsules per day, each containing 250 mg of Hesperetin and 50 mg Pycnogenol®).
China Medical University, Taichung
China Medical University, Taiwan
OTHER
China Medical University Hospital
OTHER